Our previous studies of alveolar macrophages from untreated PAP patients demonstrated dramatically reduced PPARγ and ABCG1 expression that was reversible by either in vivo or in vitro GM-CSF treatment [11,12]. The gene discussed is CSF2; the disease is pulmonary alveolar proteinosis.